Pangenomic Health Inc. (CSE:NARA)
Canada
· Delayed Price · Currency is CAD 2.230
+0.240 (12.06%)
Aug 15, 2025, 3:59 PM EDT
Pangenomic Health Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Cash & Equivalents | 0 | 0 | 0.01 | 0.09 | 1.35 | 0.04 | Upgrade
|
| Cash & Short-Term Investments | 0 | 0 | 0.01 | 0.09 | 1.35 | 0.04 | Upgrade
|
| Cash Growth | -91.33% | -89.59% | -85.81% | -93.44% | 3427.93% | 1604.28% | Upgrade
|
| Other Receivables | 0.03 | 0.03 | 0.04 | 0.16 | 0.04 | 0.01 | Upgrade
|
| Receivables | 0.03 | 0.03 | 0.04 | 0.19 | 0.04 | 0.11 | Upgrade
|
| Prepaid Expenses | - | 0 | 0.01 | 0.2 | 0.28 | 0 | Upgrade
|
| Total Current Assets | 0.03 | 0.04 | 0.06 | 0.48 | 1.67 | 0.15 | Upgrade
|
| Property, Plant & Equipment | 0 | 0 | 0.01 | 0.02 | 0.02 | - | Upgrade
|
| Other Intangible Assets | - | - | - | - | 0.85 | - | Upgrade
|
| Total Assets | 0.04 | 0.04 | 0.07 | 0.5 | 2.58 | 0.15 | Upgrade
|
| Accounts Payable | 1.02 | 1.14 | 0.8 | 0.37 | 0.17 | 0.05 | Upgrade
|
| Accrued Expenses | - | - | - | - | 0.16 | 0.06 | Upgrade
|
| Short-Term Debt | - | - | 0.96 | 0.1 | - | 0.03 | Upgrade
|
| Other Current Liabilities | 0.96 | 1.3 | 0.45 | 0.24 | - | - | Upgrade
|
| Total Current Liabilities | 1.97 | 2.44 | 2.22 | 0.72 | 0.33 | 0.14 | Upgrade
|
| Total Liabilities | 1.97 | 2.44 | 2.22 | 0.72 | 0.33 | 0.14 | Upgrade
|
| Common Stock | 14.96 | 14.21 | 12.07 | 11.24 | 4.63 | 0.2 | Upgrade
|
| Retained Earnings | -22.16 | -21.76 | -17.95 | -14.98 | -2.99 | -0.34 | Upgrade
|
| Comprehensive Income & Other | 5.27 | 5.14 | 3.74 | 3.53 | 0.1 | 0.15 | Upgrade
|
| Total Common Equity | -1.94 | -2.41 | -2.14 | -0.22 | 1.75 | 0.01 | Upgrade
|
| Shareholders' Equity | -1.94 | -2.41 | -2.14 | -0.22 | 2.24 | 0.01 | Upgrade
|
| Total Liabilities & Equity | 0.04 | 0.04 | 0.07 | 0.5 | 2.58 | 0.15 | Upgrade
|
| Total Debt | - | - | 0.96 | 0.1 | - | 0.03 | Upgrade
|
| Net Cash (Debt) | 0 | 0 | -0.95 | -0.01 | 1.35 | 0.01 | Upgrade
|
| Net Cash Growth | - | - | - | - | 12472.22% | 378.24% | Upgrade
|
| Net Cash Per Share | 0.00 | 0.00 | -0.48 | -0.01 | 3.41 | 0.09 | Upgrade
|
| Filing Date Shares Outstanding | 13.9 | 14.05 | 6.4 | 1.99 | 0.77 | 0.12 | Upgrade
|
| Total Common Shares Outstanding | 13.9 | 6.4 | 2.1 | 1.89 | 0.77 | 0.12 | Upgrade
|
| Working Capital | -1.94 | -2.41 | -2.16 | -0.23 | 1.34 | 0.01 | Upgrade
|
| Book Value Per Share | -0.14 | -0.38 | -1.02 | -0.11 | 2.25 | 0.09 | Upgrade
|
| Tangible Book Value | -1.94 | -2.41 | -2.14 | -0.22 | 0.9 | 0.01 | Upgrade
|
| Tangible Book Value Per Share | -0.14 | -0.38 | -1.02 | -0.11 | 1.16 | 0.09 | Upgrade
|
| Machinery | - | - | - | 0.04 | 0.03 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.